← Back to all trials
Active Not Recruiting
NCT05737602
Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease
Conditions: Von Hippel-Lindau Disease, Genetic Disorder
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 40
Sponsor: Massachusetts General Hospital
Location: Massachusetts General Hospital Cancer Center Boston Massachusetts
Summary
The Relaxation Response Resiliency Program (3RP) has shown efficacy in improving coping and resilience across diverse populations; however, little is known about how it helps individuals manage the challenges of living with a chronic illness. This study proposes to pilot test an adapted version of the 3RP among patients living with VHL.
Eligibility Criteria
Inclusion Criteria:
* Ages 18+
* Confirmed diagnosis of VHL
Exclusion Criteria:
* Is medically, psychiatrically, or otherwise unable to participate (as determined by a physician or study PI).
* Unwilling or unable to participate in study sessions delivered via Partners Telehealth videoconferencing.
* Participated in Phase 1 qualitative interview.
Source: ClinicalTrials.gov (NCT05737602). StuddyBuddy aggregates publicly available trial information.
